Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Tiny camera surgery for breast cancer may boost satisfaction, study suggests

NCT ID NCT07410728

Knowledge-focused Sponsor: Xijing Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked back at the records of 471 women who had breast cancer surgery with immediate implant reconstruction. It compared a newer method using a tiny camera through small cuts (endoscopic) to the traditional method with a larger cut. The goal was to see which approach leads to fewer complications and better patient satisfaction and quality of life. No new treatments were given; the study simply analyzed existing data to help guide future choices.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this study could help doctors and patients choose the better surgical option for breast cancer treatment and reconstruction, improving recovery and quality of life.
What could go wrong
This is a retrospective review of past records, not a controlled experiment. Results may be influenced by factors like patient selection, and cannot prove one surgery is definitively better.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

471 people

The number who actually took part.

Started

Apr 2021

Finished

Jul 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

This retrospective cohort study included adult female patients diagnosed with breast cancer who underwent nipple-sparing mastectomy (NSM) with immediate implant-based reconstruction at a single academic hospital between April 2021 and April 2024. Patients were categorized based on the surgical approach they received: endoscopic NSM (E-NSM) or conventional NSM (C-NSM).

Ages

18 to 65 years

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Female patients aged 18-65 years * Preoperative pathological confirmation of breast malignancy via core needle biopsy (including phyllodes tumors, borderline lesions, or BRCA gene mutations undergoing prophylactic mastectomy) * Imaging or intraoperative examination confirming no invasion of the tumor into the skin, subcutaneous tissue, or chest wall * Contraindications to breast-conserving surgery or patient-initiated choice to undergo total mastectomy with immediate reconstruction Exclusion Criteria: * Patients undergoing delayed breast reconstruction * Severe cardiopulmonary dysfunction or psychiatric disorders * History of breast plastic surgery * Long-term smokers * Inflammatory breast cancer * Diabetic patients with poorly controlled blood glucose

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Breast cancer are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

breast cancer breast neoplasm phyllodes tumor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Breast cancer Breast reconstruction

Contacts and locations

Locations

  • The First Affiliated Hospital of the Air Force Medical University

    Xi'an, Shaanxi, 710032, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.